Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by noodleyon Mar 22, 2011 10:20pm
309 Views
Post# 18325511

RE: Typical stages for Bio

RE: Typical stages for Bioagree with everything you said, aogee.  while the overnight deal might be for the greater good....short term it's gonna hurt.  even if the sp climbs to .14 - .16 ....i suspect a ton of folks are gonna say enough is enough..and three years is just way too long.  thought we were gettin near scoring position.  turns out to be a fumble.  again.  grrrrrrrr. 
Bullboard Posts